# Efficacy and Safety of Peginesatide (AF37702) in the Treatment of Anemia in Participants With Chronic Kidney Disease

> **NCT00314795** · PHASE2 · COMPLETED · sponsor: **Takeda** · enrollment: 22 (actual)

## Conditions studied

- Anemia
- Chronic Kidney Disease
- Chronic Renal Failure
- Pure Red Cell Aplasia

## Interventions

- **DRUG:** Peginesatide

## Key facts

- **NCT ID:** NCT00314795
- **Lead sponsor:** Takeda
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-04-06
- **Primary completion:** 2016-10-24
- **Final completion:** 2016-10-31
- **Target enrollment:** 22 (ACTUAL)
- **Last updated:** 2019-03-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00314795

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00314795, "Efficacy and Safety of Peginesatide (AF37702) in the Treatment of Anemia in Participants With Chronic Kidney Disease". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00314795. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*